Altogether, a better understanding of the connection between the regulation of rDNA through copy number and transcription and ribosome biogenesis in cancer may lead to the identification of additional biomarkers to predict sensitivity towards PolI inhibitors or other ways to interfere with aberrant ribosome biogenesis. The gene discussed is POLI; the disease is cancer.